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Review Article
AbstractThe dose calculation algorithms, integrated in a radiotherapy treatment planningsystem, use different approximations to swiftly compute the dose distributions.Any biological effect is somehow related to the dose delivered to the tissues. Thus,the optimization of treatment planning in radiation oncology requires, as a basis,the most accurate dose calculation to carry out the best possible prediction of theNormal Tissue Complication Probability (NTCP), as well as Tumor ControlProbability (TCP). Presently, a number of bio-mathematical models exist toestimate TCP and NTCP from a physical calculated dose using the differential dosevolume histogram (dDVH). The purpose of this review is to highlight the linkbetween any change of algorithms and possible significant changes of DVH metrics,TCP, NTCP and even more of estimated Quality-adjusted life years (QALY) based onpredicted NTCP. The former algorithms, such as pencil beam convolution (PBC)algorithm with 1D or 3D density correction methods, overestimated the TCP whileunderestimating NTCP for lung cancer. The magnitude of error depends on thealgorithms, the radiobiological models and their assumed radiobiologicalparameters setting. The over/under estimation of radiotherapy outcomes canreach up to 50% relatively. Presently, the anisotropic analytical algorithm (AAA),collapsed cone convolution algorithm (CCC), Acuros-XB or Monte Carlo are themost recommended algorithms to consistently estimate the TCP/ NTCP outcomesand QALY score, to rank and compare radiotherapy plans, to make a useful medicaldecision regarding the best plan. This paper points out also that the values of theNTCP radiobiological parameters should be adjusted to each dose calculationalgorithm to provide the most accurate estimates.
Keywords: Dose calculation algorithm, Radiobiological models, Medical decision.
1. IntroductionThe advance and development in radiation therapyoffers substantial improvement in clinical accuracy interm of delivered dose compared with formercalculation methods. The delivered dose should becalculated with a dose calculation algorithm integratedinto a treatment planning system (TPS) connected to theirradiation machines, mostly linacs. This advance allowsto deliver more exactly the desired prescription dose to
maximize the Tumor Control Probability (TCP) fortargets while minimizing the dose to normal tissues,thus minimizing the Normal Tissue ComplicationProbability (NTCP) for organs at risk (OARs). TheInternational Commission on Radiation Units andMeasurements (ICRU) has recommended an overall doseaccuracy within ± 5%.1 Considering the otheruncertainties resulting from patient setup, delineation,
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machine calibration, it is necessary to have a dosecalculation algorithm that can predict dose distributionwithin less than 3% accuracy. In this case, considering3% uncertainty from dose calculation, is resulting in anoverall uncertainty of 5.1% for the present state of theart and 3.8 % for future development.2 However, for adecade, the dose was calculated using Clarkson or pencilbeam convolution (PBC) methods without heterogeneitycorrection. The more accurate algorithms account forthe heterogeneity correction of tissues.3-8 Nowadays, aclinically relevant quantification of radiotherapy planscan be obtained with radiobiological models as thosecomputing TCP and NTCP.9 However, there is aconsiderable risk that the TCP/NTCP predictioncalculated with recent algorithm are computed applyingformer radiobiological parameters established for olderalgorithms. In this paper, we raise the questions aboutthe validity of clinical/radiobiological parameters; whichalgorithm can be used to rank radiotherapy plans usingTCP/NTCP scores; and what is the correct way ofestimating TCP/NTCP values if the medical decision isbased on radiobiological outcomes?There are two folds for answering these questions.Firstly, the most important one is the dose calculationalgorithm. Nevertheless, the problem is that animproved accuracy in the dose calculation does notnecessarily yield an improved accuracy of the predictedNTCP. Thus, the second fold is radiobiological models.These models are based on the previous and less precisealgorithms combined with old clinical outcomes. In thispaper, we address the methods to manage this issue andtake with confidence the right medical decision tocompare and rank radiotherapy plans to select the besttreatment for patients.
2. Dose calculation modelsA radiotherapy X-Ray beam contains a spectrum ofprimary photons originating directly from the target hitby the primary accelerated electrons, extra-focalhead-scattered photons produced by the primaryphotons interacting in the accelerator head and thecontaminating charged particles, secondary electrons,produced in these interactions. The dose deposited intothe patients can be divided into primary dose andsecondary dose. The dose deposited by the chargedparticles (electrons) launched by the direct photons firstinteractions, in the tissues, is referred to as the primarydose. The dose deposited as a consequence of scatteredphotons interactions is called the secondary dose orscattered dose. The dose deposition is influenced by thedensity of the tissues and its variations according to theanatomic properties of the body. These heterogeneitiesare therefore an important concern for dose calculation.However, there are various methods to take account for
the heterogeneities correction of tissues.2,10 We willcategorize these methods into two categories: methodsbased on empirical inhomogeneity correction factor (CF)and methods based on superposition convolution (SC).
2.1. Methods based on empirical inhomogeneity
correction factorThese methods take into account tissues densityinformation either in one-dimensional (1D) or the fullthree-dimensions (3D) of along a ray path from thesource to the point interest. The inhomogeneity’scorrection are handled by an equivalent path length(EPL) scaling, Batho Power law (BPL), Modified Batho's(MB) density correction or equivalent tissue-air ratio(EqTAR). Basic tissues density information are drawnfrom CT-scan (tomodensitometry) Hounsfield-units.







where ρw is the density of water and ρ(z") is the densityat local depth (z") which is calculated from CT-scanimages. Thus, the dose is corrected by replacing thecalculated EPL (z').
2.1.2. BPL and MB methodsThe correction factor suggested by Batho as an empiricalcorrection to account for both primary beam attenuationand scatter changes within water and below a single slabof lung material with density relative to water of 0.35.11Sontag and Cunningham generalized the method tohandle arbitrary densities and non-water likematerials12. Later, Webb, Fox and Cassell et al., wentfurther to allow for multiple regions of slab-likematerials.13,14 Finally, El-Khatib and Thomas showedthat the correction factor should be based on build-updepth-shifted Tissue Maximum Ratio (TMR) instead ofthe initially proposal using Tissue Air Ratio (TAR) 15,16:
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 (2)where, µm and µw are the linear attenuation coefficientsof the material in layer m and water respectively; Zbu isthe build-up depth and Zm is the distance along the beamfrom the surface to the layer m in the phantom.
2.1.3. EqTARThe correction factor proposed by Sontag et al, allows tocorrect the inhomogeneities in the patient anatomy in3D density data.17,18 This method applies a ray trace todetermine the change in the primary dose and calculatethe scatter dose. EqTAR method is based on thedensity-scaling theorem. For heterogeneity correction,this method use TAR dependent on the effective beamradius (ρr) to take account of scattered radiation andeffective depth (ρd) for primary beam correction. Thismeans the depth and the radius are scaled according tothe relative electron density of the heterogeneousmedium. The correction factor is given by:
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2.2. Methods based on superposition convolutionPhotons can travel large distances and the energy anddirection of a primary photon is independent of where itinteracts. The energy deposition by secondary particlesaround a primary photon interaction can be describedby a “kernel”. Energy deposition kernels are defined asthe distribution of energy imparted to volume elements(per unit volume) in a medium, commonly water, due toan elemental photon beam interaction at the origin ofthe coordinates of the kernel. Energy deposition kernelsare categorized according to the geometry of theelemental beam that delivers the incident energy: Pointkernel describing the pattern of energy deposited in aninfinite medium around a primary photon interaction; orpencil kernel describes the energy deposition in asemi-infinite medium from a point mono-directionalbeam and a planar kernel describes the forward andbackward energy spread from primary interactionslocated in a plane, laterally oriented in an infinite broadbeam.2 Figure 1 shows the irradiation geometries forpoint kernels, pencil kernels and planar kernels. Theisodose curves are shown as full curves.
Figure 1: Irradiation geometries for point kernels, pencilkernels and planar kernels. The isodose curves are shownas full curves (from Anders et al. 2).
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sD r T s c h c r s d s   (6)One of the disadvantages in using a point kernel is that itis quite time consuming. Several methods can be usedfor direct summation of density scaled kernels in dosecalculations. These methods include the use of Fouriertransforms, correction factor and Collapsed ConeConvolution (CCC). For CCC, Ahnesjo et al. 1989, appliesan angular discretization of the kernel which enables anefficient approach for energy transport anddeposition.19,20 Angular discretization of aparameterized point kernel yields, for each discreteangular sector (cone) i, the energy deposition per radialdistance as:
2( , ) ( ) /a r b rh r A e B e r      (7)where, AΩ, aΩ, BΩ and bΩ are fitting parametersdepending on the scattering angle Ω. The first termdescribes the primary dose and the second termdescribes scatter dose.
2.2.2. Pencil beam kernel modelsThe pencil kernel describes the energy deposited in asemi-infinite medium from a point mono-directionalbeam. For the purpose of treatment optimization,Gustafsson et al 21 used a formulation for radiotherapydose calculation:
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is  the corresponding pencil kernelfor energy deposition per unit mass at r due to primaryparticles entering the patient at s.Ahnesjo et al.22 expressed that pencil kernels incylindrical coordinates (r,z) can be accurately calculatedas:
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  (9)where, Az, az, Bz and bz are functions of depth.Pencil kernel models are effectively hybrid algorithmsthat fully account for beam modulations and field shapesbut rely on broad beam scaling/correction methods tohandle heterogeneities and patient characteristics.Provided fluencies and kernels are properly normalized,the dose is calculated in absolute units that can be usedto derive output factors. The two main accuracylimitations of pencil kernel models are forheterogeneities and for scatter dose calculations inpatient sizes.23, 24
2.3. Monte Carlo dose calculation methodThe Monte Carlo (MC) dose calculation method is themost accurate algorithm and has always been used tocompare the dose distributions with dose calculationalgorithms. The MC method uses photon and electrontransport compounds to consider the trajectories ofindividual particles and thus the pattern of dosedeposition. Each particle history is determined by therandom number generator and millions of particles
histories are traced. Thus, MC calculations are verymuch time consuming. The dose distribution is built bysumming the energy deposition in each particles history.This method models each photon interaction in thepatient. MC method uses the photon interactionprobabilities and has the potential to model the electrontransport taking explicitly account for densitycorrection. This method was used as an R&D tool and itwill be used in future for clinical use. The use ofMC-based methods is effective in some radiationoncology departments for the verification of TPS dosecalculations.25In this context, Acuros XB (AXB) uses a sophisticatedtechnique to solve the linear Boltzmann transport (LBT)equation and accounts the effects of heterogeneities inpatient dose calculations. AXB provides comparableaccuracy to MC with improved calculation speed.
3. Dose calculation algorithms
integrated in TPSNumerous studies in the literature have categorized thedose calculation methods according to variouscriteria.26-28 They classified the algorithms into threetypes according to whether they take into account, ornot, the tissue density correction and include, or not,electron transport. In this review, we also chose tocategorize the available methods into three typesaccording to the concept used to take account of thetissues density correction. The Table 1 shows theavailable models and algorithms for radiotherapy. TheTable 2 shows the methods for dose calculationalgorithms and its ability to take into account the dosecompositions for 1D or 3D heterogeneity correctiontissues. The (+) shows that the algorithm take intoaccount the corresponding dose component, but (–)shows that the algorithm does not take into account thecorresponding dose component.
Table 1: The available models and algorithms for radiotherapy.Types Models Description Algorithms in TPS
A Inhomogeneitycorrection factor -models do not account for changes in lateral electron transport.-reconstructs measured dose by interpolating profiles and depthdoses. EPLBPL, MB, EqTARPencil kernel -methods superpose predetermined dose distributions fromnarrow pencils of radiation in water. PBC
B Point kernel -calculates primary photons transfer energy to secondaryparticles.-dose deposition from all secondary’s handled by means of(pre-calculated, heterogeneity scaled) point kernels.
AAACSCC
C
Grid basedBoltzmann solvers -calculates primary photons transfer energy to secondaryparticles. AXBMonte Carlo -simulates the fate of individual particles by using randomnumbers.-calculation of primary photons transfer energy to secondaryparticles for variance reduction.
MC
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Table 2:Methods for dose calculation algorithms and their ability to take into account the dose component for 1D or 3Dtissues heterogeneity correction. The (+) and (–) shows the level of performance of the different algorithms regarding theitems listed in the table.Calculationmethods Algorithms Dose compositions Heterogeneitycorrection Accuracy SpeedPrimaryphotons Scatteredphotons ContaminatingelectronsPrimary withScattered Clarkson + + - none + ++SuperpositionConvolution PBC alone + + - none + ++PBC withcorrectionfactor
PBC-EPLPBC-MBPBC-BPL + + - 1D ++ ++EqTAR + + - 3D ++ ++
SuperpositionConvolution
Pencil beamkernel(AAA) + + + 3D +++ ++PointkernelsCCC + + ++ 3D ++++ ++LBT AXB + + +++ 3D ++++ +MC MC + + +++ 3D +++++ -
4. Modernization of radiotherapy
outcomes from the calculated doseThe Figure 2 shows the multiple outcomes to which thedose calculation algorithms are contributing inradiotherapy.
Figure 2: The main outcomes the dose calculationalgorithms make possible to compute in radiotherapy.
4.1. Radiobiological evaluationBoth TCP and NTCP can be calculated using thedifferential dose volume histograms (dDVH). The mainobjective is to use the biological models to predict the
RT outcomes, from the dose distribution, and to makethese biological estimates as accurate as possible. Forthis purpose, biological models are now integrated insome TPS to compare RT plans, and thus to be able torank them. Therefore, the DVH metrics can be used toevaluate the biological response and to predict theoutcome of different plans. However, there are severalbiological models to predict TCP and NTCP.29-44 Themost common TCP model is the Poisson model with theLinear-Quadratic (LQ) equation. The most commonNTCP models are the Lyman-Kutcher-Burman one(LKB), the relative seriality model (s) and the EquivalentUniform Dose (EUD). These models are included in someTPS.45 The Table 3 shows the most common TCP andNTCP radiobiological models integrated in TPS. One ofthe limit is that there is a variability of radiobiologicalparameters setting in the literature. The LKB modeldescribes complication probabilities for uniformlyirradiated whole or partial organ volumes. Thecumulative distribution function of the normaldistribution is chosen to represent an empirical sigmoiddependence of NTCP on dose. The shape of the NTCPrelation is determined by three parameters: TD50, m andn. TD50 and m, describe the position of the sigmoid curvealong the dose axis and curve steepness, respectivelyand n describes the magnitude of the volume effect usinga power-law relationship between the tolerance doseand irradiated volume. The s-model describes responseof an organ with a mixture of serial and parallelarranged Functional Sub-Units (FSUs). The relativecontribution of each type of architecture is described bythe parameter “s”, which is equal to unity for a fullyserial organ and zero for a fully parallel organ.Generalized gEUD can also be used to predict TCP/NTCP
6 Chaikh et al.: Impact of dose calculation algorithms on medical decisions International Journal of Cancer Therapy and Oncology
www.ijcto.org
© Chaikh et al. ISSN 2330-4049
from the physical dose, DVH, for treatment planoptimization and to rank treatment plans. Thus, theUncomplicated Tumor Control Probability (UTCP) canbe calculated as 46:UTCP = TCP. Пi (1-NTCPi)          (10)where, “i” includes the organs at risks that should beconsidered for each cancer site.To rank a treatment plan, Langer et al, proposed theS-score 47,48:S-score = TCP. (1-NTCP)         (11)When the absolute value of NTCP is large, the score willbe very sensitive to the changes in NTCP, but when theabsolute value of NTCP is small, the score will berelatively insensitive to changes in NTCP. To avoid thisproblem, Brenner et al proposed a R-score, defined as:R-score = TCP / NTCP           (12)
4.2. Quality adjusted life years (QALY) scoreIn order to quantify the real benefit of the treatment forthe patient a combination of survival and quality of life(QoL) is provided by the QALY, the physical NTCP
predicted from dDVH should be calibrated andmultiplied with the “Utility value”, calculated as49:NTCP(QALY)= NTCP *U{I = 1 to m} (13)where, U varied from zero to 1, including age, thenumber of years of survival expected as a benefit of theradiotherapy cure, grade, etc.
4.3. Secondary cancer risk estimationThe risk of secondary cancer is a rising concern amongthe growing population of patients having been cured ofa first cancer. In the recent years, models of the risk ofsecondary cancer have been proposed and integrated inTPS.74 As for other radiobiological estimates, theestimation of the 2nd cancer risk for a specific organcould be derived from DVH metrics using the organequivalent dose (OED) model. The OED for a bell shapedrisk relationship can be calculated as75-77:
1






  (14)where, N is dose calculation points, Di is thecorresponding absorbed dose and αorg is anorgan-specific parameter related to the dose-responsederived from the fitting of the model to the Hodgkin’scohort data.
Table 3: The most common TCP and NTCP radio biological models integrated in TPS.Models Structure type Parameters Equations
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The OED is defined as the uniform irradiation dose of anorgan that will yield the same secondary cancer risk as the inhomogeneous dose-distribution on which theOED-calculation is based. The secondary cancer risk is
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by definition dependent on the OED and can becalculated as:Iorg = I0org ⋅OEDorg (15)where, I0org is the organ-specific secondary cancerincidence related to low-dose exposure e.g. as providedby the Life Span Study (LSS).78
5. Impacts of the changes of dose
calculation algorithms on the
delivered dose and radiotherapy
outcomes
5.1. Influence of dose calculation algorithms on
the delivered dose and monitor unitesThe change of TPS algorithm, still prescribing the samedose, leads to two dose related effects. Firstly, thedelivered dose at the isocentre will change due to thefact that a different number of monitor units (MUs) willbe calculated. Secondly, the relative dose distributionwill change showing a spatial variation in dosedistribution. Chaikh et al, proposed a normalized MUsmethod to compare different dose calculationalgorithms.50,51The Figure 3 shows a method to compare the dosecalculation algorithms and readjust the prescriptiondose using “fixed monitor units normalization” method.This method is based on the use of MUs from formeralgorithm, as input, and keeping the same field geometryand beam arrangement to re-calculate the dose with the
newer one. To measure the magnitude of dose differencea 2D gamma maps was also proposed.52 The Figure 4shows the MUs calculated from PBC, PBC-MB and AAAnormalized to 100%. The MUs were calculated for thesame patients using the same prescribed dose and beamarrangement. The calculated dose to 95% of the targetvolume (D95%) in Figure 4 was firstly calculated withPBC and re-calculated with AAA, CCC and MC, using MUsfrom PBC, as input. The PBC was taken as the referenceone, to show the impact on prescribed dose whenmoving to new generations of TPS.53,54 The results fromFigure 4 confirm that the PD should theoretically bereadjusted by the radiation oncologist using the newalgorithm. When the fixed MUs normalization is used torecalculate the PD at the isocentre inside the PTV orD95% from dose volume histograms, both PD and D95%were significantly different, especially for thoraxirradiation, due to the most important heterogeneities oftissues’ density in the thorax. In this context, areadjustment should be considered for thoraxirradiations when moving from PBC to 1D or 3D densitycorrection methods, such as PBC-MB, PBC-BPL orPBC-EqTAR. Then another re-adjustment of -5% shouldbe done when moving from PBC with 1D/3D densitycorrection methods to AAA.55 It worths to be mentionedthat the modification of PD varies in opposite senses inthese two former situations, which can confuse the user!We recommend a local comparison of the algorithmssince the differences depend also on the habits of use, ofbeam arrangements, energy and normalization of PD.
Figure 3: A method to compare the dose calculation algorithms and readjust the prescription dose (from Chaikh et al. 26).
8 Chaikh et al.: Impact of dose calculation algorithms on medical decisions International Journal of Cancer Therapy and Oncology
www.ijcto.org
© Chaikh et al. ISSN 2330-4049
Figure 4: Normalized MUs and calculated dose to 95% of target (D95%) using types ‘A’, ‘B’ and ‘C’ algorithms for lung fromRT-3D. The left upper panel shows the MUs normalized to 100% with PBC taken as the reference one vs types ‘A’ and ‘B’,respectively with MB and AAA. The right upper panel shows the MUs normalized to 100% with AAA taken as the referenceone vs type ‘C’ as AXB(Dm) indicating dose to medium or AXB(Dw) indicating dose to water. The MUs were calculated for thesame patients using the same prescribed dose and beam arrangements. The D95% were recalculated using MUs from PBC asinput (from literature).
5.2. Influence of dose calculation algorithms on
TCP/NTCP outcomesThe impact of the change of dose algorithms on tumorcoverage, TCP or NTCP, has been investigated by severalstudies.56-67 The American Association of Physicists inMedicine (AAPM) report number 85 on tissueinhomogeneity corrections mentioned that a 5% changein dose might result in a significant change in TCP andNTCP. The studies reported that the photon dosecalculation algorithm has a significant impact onradiobiological metrics. They showed that there-evaluation of NTCP model parameters is necessarywhen more accurate dose data are available to avoidover or underestimated NTCP. Chetty, et al, showed thatan average TCP decrements up to 50%, can be observedwith the EPL model. Liu, et al, also reported that EPLoverestimates TCP by 20-50%. Chaikh, et al. 2016,reported that the TCP/NTCP is strongly affected by thewide-ranging values of radiobiological parameters andthe differences between the dose distributions fromvarious algorithms yield statistically differences in both
TCP and NTCP values. For instance, they showed thatNTCP values for pneumonitis are very sensitive to thechoice of the algorithm, as they are to the doseconstraints: V20 Gy, V30 Gy, and mean dose.
5.2.1. Sensitivity of radiobiological parameters
settings with the change of dose calculation
algorithmFor both LKB and s-model, presented in this study, theneed to readjust clinical parameters due to the change ofdose calculation algorithm is reported by severalstudies, and the shifts of these parameters were alsopublished. Lung pneumonitis as endpoint has beenchosen as the focus of the present paper, because thedifferences of doses calculated by the algorithms, oftypes ‘A’ or ‘B’ and ‘C’, have a large impact on the dosedistributions in the highly inhomogeneous thoracicregion due to lower lung density. Nevertheless, the mostimportant effect is when moving from type ‘A’ to type ‘B’.This effect can be found in other anatomical regions;
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however, the magnitude of changes is depending ontarget location. Therefore, should the user use theTCP/NTCP to rank treatment plans using published data,he/she will introduce extra uncertainties leading toover/under prediction of TCP/NTCP values. Thus, oneshould check that the parameters are well adapted tothe used algorithm type. In this context, we advise theuse of the recommended radiobiological setting for theadapted algorithm. The Table 4 shows the compilation ofthe radiobiological settings, for lung pneumonitis, forseveral dose calculation algorithms.
Table 4: The suggested radiobiological settings for lungpneumonitis for several dose calculation algorithms.Literature proposals n m TD50 (Gy)Initial data68,69 0.87 0.18 24.50Grade ≥ 270 0.99 0.37 30.8Grade ≥ 2 with NTD71 1 0.3 30.5EPL72 1.0 0.45 34.1CS72 1.0 0.45 29.2PBC73 0.99 0.37 30.78AAA73 0.99 0.374 29.19
5.2.2. Clinical utility of TCP/NTCP to compare
radiotherapy plansThe present review establishes one example of thegeneral need to change the parameters values accordingto the algorithm types and to define a level of NTCP inabsolute and relative values, to rank treatment plans toselect the best one to treat a patient. The Figure 5 showsthe NTCP values, as an example, from the treatment of alung cancer with prescription doses varying from 50 to66 Gy. The NTCP were estimated using LKB model andbootstrap simulation method based on 1000 replicationsfor lung radiation pneumonitis. For all NTCP calculationsthe AAA-calculated DVH was used as input data. TheNTCP values were obtained using the radiologicalparameter settings given in Table 4.
Figure 5: The NTCP values for lung radiation pneumonitisfrom treatment of lung cancer. The NTCP were estimatedwith LKB model using the various radiological parameterssetting given in Table 4. The DVH in any case was calculatedusing AAA .Assuming AAA is closer to the physical reality, the NTCPestimated with AAA adapted parameters yield about 5%,although NTCP calculated with CS parameters yieldsoverestimated NTCP absolute values > 10% and NTCP
calculated with the “initial data” are very low <5% andprobably underestimated. Thus, in this case, thevariation of absolute NTCP is clinically questioning.It is, however, not the NTCP itself that is presently ourmain interest, but the critical need to adapt the NTCPparameters to the dose calculation algorithm used forthe treatment planning. On the other hand, the ΔNTCP,as relative values, could reach 50%, depending on themodel parameter values.
5.3. Influence of dose calculation algorithms on
QALY scoreSince, the predicted TCP/NTCP depends on theperformance of dose calculation methods, as mentionedabove, the comparison of DVH metrics should be carriedout using the most accurate dose calculation algorithms,and after a major effort to optimize the plans. Then, forPTV and OARs, the DVH metrics can be used to select thebetter plans by comparing TCP/NTCP and UTCP. As anexample, AAA shows a significant difference comparedto pencil beam density correction methods (PB-MB orEPL). The relevant lung TCP/NTCP data show lower TCPand higher NTCP with AAA compared to MB. Using thedata from MB will probably significantly overestimatethe predictive QALY, justifying the use of more accuratealgorithms.
5.4. Influence of dose calculation algorithms on
second cancer risk estimation in radiotherapyThe dose calculation algorithms use differentapproximations to compute the dose distributions. Theshift on DVH bins resulting from the change of algorithmcan influence the OED values. Since the more advancedalgorithms predicted a significant dose difference toOARs, the OED will be significantly over/underestimated predicting more/less risks compared toformer algorithms. Thus, the use of dose calculationmethod that compute the dose using primary dose withscatter dose would yield wrong results for secondarycancer risk estimation, since the dose distribution fromelectrons transport is very important, especially inthorax region including breast, lungs and esophagus.The risk of secondary cancer for young patients is moreimportant than for aged patients, this risk should beproperly estimated in children by using more accuratealgorithms showing the best, if not “real”, DVH. Forexample, in paediatric medulloblastoma with RT-3D, theAAA yield more average dose for lung compared withPBC-MB. Thus, the OEDs for lung from a bell shaped riskrelationship model, equation 14, with αlung = 0.129 were1.84 Gy and 1.72 Gy using respectively, AAA andPBC-MB. A significant difference for DVH for thoraxorgans could also be observed using 18 MV compared to6 MV depending on the performance of algorithm.In addition, for proton radiotherapy, the algorithmsshould also integrate the contribution of neutroncontamination of proton beam. For example, whenirradiating the brain with proton therapy the neutron
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contamination could potentially increase theradiation-induced secondary tumors.
6. DiscussionThe former radiobiological parameters such as γ, n, m,TD50, etc. were validated using clinical data obtainedwith the less accurate type ‘A’ algorithm. Hence, usingthese former clinical data to recalculate the TCP/NTCPusing, as input, DVH calculated with the latestalgorithms will introduce errors for estimatedTCP/NTCP. The application of readjusted parametersadapted to these updated algorithms, for each specificmodel, will result in more accurate TCP/NTCP. In thispaper, we reviewed the commonly used dose calculationalgorithms types. We showed that significant dosedifferences could be observed either for DVHs for targetvolumes or OARs introducing considerable over/underestimations of TCP/NTCP metrics. However, thecomparison of treatment plans using the former clinicaldata might be useful to estimate the magnitude ofuncertainties for the model parameters values. Theuncertainties can be evaluated and presented asconfidence interval using bootstrap simulation method.We advise that the change of dose calculation algorithmsshould be performed with a lot of care since the clinicalknowledge’s are based on the former algorithms and thenew algorithm will need more accurate NTCPparameters.We advise, if possible, to locally calibrate aradiobiological model to better predict the toxicity. Oneof the solution is to correlate a kind of integratedmeasure of the Qol with the calculated toxicity. In thiscontext, we can consider two categories of toxicity:
 The first category includes a moderate toxicity,the “acceptable risk of radiations”, which doesnot affect Qol of the patient. In this case, a localcalibration of the parameter setting could becarried out, or a simple estimation of NTCPcould be done using published data. In this case,the calibration should only include the toxicityrelated to irradiation, e.g. cataract or trouble ofvision, but the Qol could be rather insensitive.
 The second category includes “unacceptablerisk of radiations” which affect the Qol of thepatient. In this case, the risk cannot occurwithout delivering a certain amount ofradiations to OARs, and the Qol could besignificantly altered leading to a considerableimpact, like complete blindness, or even deathby severe radiation pneumonitis. In these cases,one must limit the radiation dose to the OARs inorder to avoid these effects. This could need todecrease the delivered dose to the tumor targetand thus altering the TCP. In this case, a reliablebalance between TCP and NTCP prediction
should be available. For this, beyond the use ofthe most updated dose calculation algorithmsand the most adapted radiobiologicalparameters, as mentioned before, weightingfactors taking account of the age and thecomorbidities of the patients should ideally beassociated to this balanced prediction ofoutcome. This is presently mainly the radiationoncologist experience that allows thiscompromise.
Table 5: A list of TPS and algorithms for dose calculationtested by the IROC Houston through the irradiation of thelung phantom.TPS AlgorithmAccuray Multiplan MCAccurayTomoTherapy CSBrain Lab IPlan MCElekta Monaco XVMC or CCCElekta XiO Multi-grid Superposition or FastSuperpositionPhillips Pinnacle CCC or Adaptive ConvolveProwess Panther CCCRaySearchRayStation CCCVarian Eclipse AAA or AXBHelax CCNomos Corvus MCAbbreviations: MC: Monte Carlo; CS:  ConvolutionSuperposition; CCC: Collapsed Cone Convolution; CC:Collapsed Cone ;AAA: Anisotropic Analytical Algorithm;AXB: Acuros-XB
6.1. Dose uniformity for lung cancer with
heterogeneity correction with types A and B
algorithmsThe DVH is the base to compute the TCP/NTCP metrics.In this section we will discuss about the alterations ofDVH which could be observed when moving from PBCwithout heterogeneity correction to correction-basedpencil beam type ‘A’ then type ‘B’ and type ‘C’algorithms. Firstly, the shape of DVH is very sensible todose calculation algorithms, photon energy andirradiation techniques. In this context, the formeralgorithms such as PBC, PBC-MB, PBC-EqTAR have morelimited accuracy for modeling the dose in the target andOARs. They overestimated the dose distribution in thetarget and thus TCP/NTCP. The PBC predicted morehomogeneous dose distribution compared with type ‘B’and ‘C’ algorithms. Using the most accurate algorithms,such as AAA, AXB or MC, the dose distribution is moreheterogeneous compared with type ‘A’ algorithms. Thedose heterogeneity inside the PTV will introduce either“cold spots” or “hot spots”. For example, AAA predictedmore heterogeneous dose than MB, as mentioned above.Secondly, the dosimetric parameters, derived from DVHcan be significantly changed. Consequently, this will leadto over/under estimating of EUD and TCP score as well
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as NTCP. For example, PBC alone, or with densitycorrection methods, erroneously predicts a higher dosein the beam entrance around the tumor located in thelung and overestimated the tumor coverage and TCP,compared with AAA.
6.2. Recommended algorithm for dose calculation
in clinical useThe CCC and AXB are superior to the PBC and type ‘A’ interms of accuracy of the calculated dose and thesealgorithms would be recommended to compare andrank radiotherapy plans. More recent studies showedthat AAA overestimates the PTV dose and TCP comparedto AXB. The difference can reach up to 5.8 % for TCP,while both algorithms yield very similar NTCP on lungpneumonitis based on the LKB model parameter.79,80Table 5 shows a list of TPS and algorithms for dosecalculation, recommended by the IROC (M.D. Anderson,Houston) through the irradiation of a lung phantom.81
7. ConclusionThe expected TCP/NTCP metrics, QALY score andsecondary cancer risk estimations, are related to theDVH metric and radiobiological tools. Among otherconsiderations, this should attract attention about thecritical choice of radiobiological parameters setting anddose calculation algorithm to better estimate TCP/NTCP,otherwise important uncertainties can be expected. Todate, only the MC method is considered the mostaccurate algorithm for dose calculation, but it requiresthe greatest processing time. Apart from MC method, allother algorithms make different degrees ofapproximation and simplification leading to lesscalculation time, but also resulting in less accurate dosedistribution comparing with the MC simulation. Therealistic approach, to choose and rank radiotherapyplans to make a clinical decision, need that the DVHshould be calculated using the more accurate algorithm.
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